During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed goals and barriers to treatment when using ...
A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial Supported in part ...
Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.
During a Case-Based Roundtable® event, Neeraj Agarwal, MD, and participants discussed how they might determine which ...
You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...
Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...
SAN FRANCISCO -- An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback